❮ Back

Investigators

Core Methods

The Core Methods group brings expertise in practices that are increasingly essential in obtaining funding for research projects, including co-design and translation, health economics, informatics and e-health technologies.


Vicki Anderson

Professor Vicki Anderson BA (Hons), MA (Clin Neuropsych), PhD, FAPS, FASSA, FAAHMS, FASSBI. Dr Anderson is Director, Clinical Sciences Research, Murdoch Childrens Research Institute, Head, Psychology, The Royal Children’s Hospital, Melbourne. Her research and clinical interests are in developmental and acquired disorders, impacting the child’s brain. Her recent work has focussed on translating her early career findings into clinical practice to optimise child outcomes from brain injury. Her achievements include publication of the Test of Everyday Attention for Children which is now adopted worldwide and development of parent-focused psychosocial treatments, including novels and digital health tools to support screening and diagnosis of childhood conditions.

Mary Lou Chatterton

Mary Lou assists in leading a team of eight health economists dedicated to evaluating interventions for the prevention and treatment of mental health conditions including bipolar disorder, schizophrenia, anxiety and depression. Her main interest and expertise concentrates on economic evaluations alongside clinical trials and she has over 25 years of experience in pharmacoeconomic /health economics research collaborating with both pharmaceutical industry and academic partners. She has been a named investigator on grants totalling $13.2 million and an author on 50 peer reviewed publications, four book chapters and five reports.

Sharon Goldfeld

Professor Sharon Goldfeld - holds a unique position within Australian child health research, with 10 years government experience she is an expert in policy, a pediatrician, and a public health clinician scientist. She is the Director of the Centre for Community and Child Health at the Royal Children’s Hospital Melbourne, Co-Group Leader of the Policy and Equity Research Group, and Theme Director, Population Health, within the Murdoch Children’s Research Institute. She has successfully translated her research into service delivery and policy including the national implementation of Early Development Instrument. Her research interests are made up of complementary, synergistic and cross-disciplinary streams of work focused on investigating, testing and translating sustainable policy relevant solutions that eliminate inequities for Australia’s children.

Stephen Hearps

Stephen Hearps is a Data Scientist/Biostatistician at the Murdoch Children’s Research Institute. His research focuses on analysis and translation of epidemiology and social and mental health outcomes of children and adolescents, primarily following paediatric injury. Stephen’s expertise is in working with various complex datasets, including nuanced clinical data, large-scale longitudinal cohort studies, and global data repositories.

Cathy Mihaopoulos

Professor Cathy Mihalopoulos is the inaugural Head of the Division of Health Economics in the School of Public Health and Preventive Medicine at Monash University. Her major field of research interest is the economics of mental health and psychosocial care, with a special focus on economic evaluation and associated methodologies. She has over 180 publications in this area and has been a named investigator on grants, tenders and consultancies totalling over $70 million dollars. She has been invited to sit on committees of national and international significance, including the Economics Sub-Committee of Australia’s Pharmaceutical Benefits Advisory Committee (PBAC).

Melissa Green

Professor Melissa Green is a Professor of Psychiatry at the University of New South Wales (UNSW, Sydney) and Group Leader at Neuroscience Research Australia. She holds an honorary appointment at Leiden University in the Netherlands. Her research is focused on determining modifiable social and biological risk factors for the development of severe mental illness, and she brings expertise in epidemiology, genetics and clinical neuropsychiatry, with particular interest in psychotic disorders.
❮ Back